{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T10:40:45Z","timestamp":1788691245989,"version":"build-2803163510"},"reference-count":40,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"DOI":"10.1001\/jamanetworkopen.2022.2735","type":"journal-article","created":{"date-parts":[[2022,3,16]],"date-time":"2022-03-16T11:02:01Z","timestamp":1647428521000},"page":"e222735","source":"Crossref","is-referenced-by-count":53,"title":["Efficacy of Losartan in Hospitalized Patients With COVID-19\u2013Induced Lung Injury"],"prefix":"10.1001","volume":"5","author":[{"given":"Michael A.","family":"Puskarich","sequence":"first","affiliation":[{"name":"Department of Emergency Medicine, University of Minnesota, Minneapolis"},{"name":"Department of Emergency Medicine, Hennepin County Medical Center, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas E.","family":"Ingraham","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa H.","family":"Merck","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Florida College of Medicine, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Driver","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Hennepin County Medical Center, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"Wacker","sequence":"additional","affiliation":[{"name":"Division of Pulmonary, Allergy, Critical Care and Sleep Medicine, Department of Medicine, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren Page","family":"Black","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Florida College of Medicine, Jacksonville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan E.","family":"Jones","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Mississippi Medical Center, Jackson"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Courtney V.","family":"Fletcher","sequence":"additional","affiliation":[{"name":"Center for Drug Discovery, University of Nebraska Medical Center, Omaha"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"South","sequence":"additional","affiliation":[{"name":"Section of Nephrology, Department of Pediatrics, Wake Forest School of Medicine and Brenner Children's Hospital, Winston Salem, North Carolina"},{"name":"Division of Public Health Sciences, Department of Epidemiology and Prevention, Wake Forest School of Medicine, Winston Salem, North Carolina"},{"name":"Department of Surgery-Hypertension and Vascular Research, Wake Forest School of Medicine, Winston Salem, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Murray","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Lewandowski","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, Henry Ford Hospital, Wayne State University, Detroit, Michigan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Farhat","sequence":"additional","affiliation":[{"name":"Department of Surgery, North Memorial Medical Center, Minneapolis, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin L.","family":"Benoit","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Cincinnati, Cincinnati, Ohio"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle H.","family":"Biros","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kartik","family":"Cherabuddi","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Florida College of Medicine, Gainesville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Chipman","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy W.","family":"Schacker","sequence":"additional","affiliation":[{"name":"Division of Infectious Disease, Department of Medicine, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faheem W.","family":"Guirgis","sequence":"additional","affiliation":[{"name":"Department of Emergency Medicine, University of Florida College of Medicine, Jacksonville"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen T.","family":"Voelker","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph S.","family":"Koopmeiners","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, School of Public Health, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J.","family":"Tignanelli","sequence":"additional","affiliation":[{"name":"Department of Surgery, University of Minnesota, Minneapolis"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew C","family":"Nelson","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Hall","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Wright","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald A","family":"Reilkoff","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tyler","family":"Bold","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth","family":"Beckman","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"Langlois","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew T","family":"Aliota","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Galbriath","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Beyer","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chas","family":"Salmen","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Byrne","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Roberts","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nastasia","family":"James","sequence":"additional","affiliation":[{"name":"for the Angiotensin Receptor Blocker Based Lung Protective Strategies for Inpatients With COVID-19 (ALPS-IP) Investigators"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2022,3,16]]},"reference":[{"issue":"1","key":"zoi220109r2","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00912-2020","article-title":"Understanding the renin-angiotensin-aldosterone\u2013SARS-CoV axis: a comprehensive review.","volume":"56","author":"Ingraham","year":"2020","journal-title":"Eur Respir J"},{"issue":"6","key":"zoi220109r3","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1016\/S2213-2600(20)30226-5","article-title":"Immunomodulation in COVID-19.","volume":"8","author":"Ingraham","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"5","key":"zoi220109r4","doi-asserted-by":"publisher","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences.","volume":"318","author":"South","year":"2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"zoi220109r5","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.625732","article-title":"Expression of ACE2, soluble ACE2, angiotensin I, angiotensin II and angiotensin-(1-7) is modulated in COVID-19 patients.","volume":"12","author":"Osman","year":"2021","journal-title":"Front Immunol"},{"issue":"1","key":"zoi220109r6","doi-asserted-by":"publisher","first-page":"L213","DOI":"10.1152\/ajplung.00129.2021","article-title":"A pilot study to assess the circulating renin-angiotensin system in COVID-19 acute respiratory failure.","volume":"321","author":"Files","year":"2021","journal-title":"Am J Physiol Lung Cell Mol Physiol"},{"issue":"5","key":"zoi220109r7","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1016\/j.pcad.2020.07.006","article-title":"Letter to the Editor\u2014circulating plasma levels of angiotensin II and aldosterone in patients with coronavirus disease 2019 (COVID-19): a preliminary report.","volume":"63","author":"Henry","year":"2020","journal-title":"Prog Cardiovasc Dis"},{"issue":"7047","key":"zoi220109r8","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/nature03712","article-title":"Angiotensin-converting enzyme 2 protects from severe acute lung failure.","volume":"436","author":"Imai","year":"2005","journal-title":"Nature"},{"issue":"5","key":"zoi220109r9","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1113\/expphysiol.2007.040048","article-title":"The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice.","volume":"93","author":"Imai","year":"2008","journal-title":"Exp Physiol"},{"key":"zoi220109r10","doi-asserted-by":"publisher","first-page":"3594","DOI":"10.1038\/ncomms4594","article-title":"Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections.","volume":"5","author":"Zou","year":"2014","journal-title":"Nat Commun"},{"issue":"8","key":"zoi220109r11","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1002\/jcph.v61.8","article-title":"The interplay between the immune system, the renin-angiotensin-aldosterone system (RAAS), and RAAS inhibitors may modulate the outcome of COVID-19: a systematic review.","volume":"61","author":"Naveed","year":"2021","journal-title":"J Clin Pharmacol"},{"issue":"6","key":"zoi220109r12","doi-asserted-by":"publisher","first-page":"e52","DOI":"10.1097\/EDE.0000000000001250","article-title":"Re: association of inpatient use of angiotensin converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19.","volume":"31","author":"Rouette","year":"2020","journal-title":"Epidemiology"},{"issue":"6","key":"zoi220109r13","doi-asserted-by":"publisher","first-page":"571","DOI":"10.1007\/s40256-020-00439-5","article-title":"Mortality and disease severity among COVID-19 patients receiving renin-angiotensin system inhibitors: a systematic review and meta-analysis.","volume":"20","author":"Hasan","year":"2020","journal-title":"Am J Cardiovasc Drugs"},{"key":"zoi220109r14","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijcha.2020.100627","article-title":"Angiotensin-converting enzyme inhibitors and angiotensin-receptor blockers and the risk of COVID-19 infection or severe disease: systematic review and meta-analysis.","volume":"31","author":"Caldeira","year":"2020","journal-title":"Int J Cardiol Heart Vasc"},{"key":"zoi220109r15","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2020.106805","article-title":"RAAS inhibitors are not associated with mortality in COVID-19 patients: findings from an observational multicenter study in Italy and a meta-analysis of 19 studies.","volume":"135","author":"COVID-19 RISk and Treatments (CORIST) Collaboration","year":"2020","journal-title":"Vascul Pharmacol"},{"key":"zoi220109r16","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2020.585866","article-title":"Comorbidities, cardiovascular therapies, and COVID-19 mortality: a nationwide, Italian Observational Study (ItaliCO).","volume":"7","author":"Polverino","year":"2020","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"zoi220109r17","doi-asserted-by":"publisher","first-page":"833","DOI":"10.1161\/HYPERTENSIONAHA.120.16314","article-title":"Antihypertensive drugs and COVID-19 risk: a cohort study of 2 million hypertensive patients.","volume":"77","author":"Semenzato","year":"2021","journal-title":"Hypertension"},{"issue":"14","key":"zoi220109r19","doi-asserted-by":"publisher","first-page":"1754","DOI":"10.1001\/jama.286.14.1754","article-title":"Serial evaluation of the SOFA score to predict outcome in critically ill patients.","volume":"286","author":"Ferreira","year":"2001","journal-title":"JAMA"},{"issue":"4","key":"zoi220109r20","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1097\/CCM.0b013e31819cefa9","article-title":"Derivation and validation of Spo2\/Fio2 ratio to impute for Pao2\/Fio2 ratio in the respiratory component of the Sequential Organ Failure Assessment score.","volume":"37","author":"Pandharipande","year":"2009","journal-title":"Crit Care Med"},{"key":"zoi220109r21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jbi.2019.103208","article-title":"The REDCap consortium: building an international community of software platform partners.","volume":"95","author":"Harris","year":"2019","journal-title":"J Biomed Inform"},{"issue":"8","key":"zoi220109r22","doi-asserted-by":"publisher","first-page":"797","DOI":"10.2165\/00003088-200544080-00003","article-title":"Clinical pharmacokinetics of losartan.","volume":"44","author":"Sica","year":"2005","journal-title":"Clin Pharmacokinet"},{"issue":"11","key":"zoi220109r23","doi-asserted-by":"publisher","DOI":"10.1088\/1361-6579\/ab5154","article-title":"Imputation of partial pressures of arterial oxygen using oximetry and its impact on sepsis diagnosis.","volume":"40","author":"Gadrey","year":"2019","journal-title":"Physiol Meas"},{"issue":"19","key":"zoi220109r24","doi-asserted-by":"publisher","first-page":"1813","DOI":"10.1056\/NEJMoa2007764","article-title":"Remdesivir for the treatment of COVID-19\u2014final report.","volume":"383","author":"Beigel","year":"2020","journal-title":"N Engl J Med"},{"issue":"1","key":"zoi220109r25","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1186\/cc11454","article-title":"Diagnosis, evaluation, and management of acute kidney injury: a KDIGO summary (part 1).","volume":"17","author":"Kellum","year":"2013","journal-title":"Crit Care"},{"issue":"5","key":"zoi220109r26","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1161\/HYPERTENSIONAHA.120.15948","article-title":"Severe acute respiratory syndrome coronavirus 2, COVID-19, and the renin-angiotensin system: pressing needs and best research practices.","volume":"76","author":"Sparks","year":"2020","journal-title":"Hypertension"},{"issue":"10","key":"zoi220109r27","doi-asserted-by":"publisher","first-page":"2092","DOI":"10.1097\/HJH.0000000000001801","article-title":"Association between preterm birth and the renin-angiotensin system in adolescence: influence of sex and obesity.","volume":"36","author":"South","year":"2018","journal-title":"J Hypertens"},{"key":"zoi220109r28","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/978-1-4939-6625-7","article-title":"Measurement of angiotensin peptides: HPLC-RIA.","volume":"1527","author":"Brosnihan","year":"2017","journal-title":"Methods Mol Biol"},{"issue":"21","key":"zoi220109r30","doi-asserted-by":"publisher","first-page":"1997","DOI":"10.1056\/NEJMoa1901686","article-title":"Early neuromuscular blockade in the acute respiratory distress syndrome.","volume":"380","author":"Moss","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"zoi220109r31","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0018166","article-title":"An assessment of H1N1 influenza-associated acute respiratory distress syndrome severity after adjustment for treatment characteristics.","volume":"6","author":"Riscili","year":"2011","journal-title":"PLoS One"},{"issue":"9","key":"zoi220109r32","doi-asserted-by":"publisher","first-page":"1200","DOI":"10.1164\/rccm.201101-0135OC","article-title":"Early corticosteroids in severe influenza A\/H1N1 pneumonia and acute respiratory distress syndrome.","volume":"183","author":"Brun-Buisson","year":"2011","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"zoi220109r33","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1007\/s00134-009-1727-6","article-title":"H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment.","volume":"36","author":"Quispe-Laime","year":"2010","journal-title":"Intensive Care Med"},{"issue":"3","key":"zoi220109r34","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0248956","article-title":"Characterizing COVID-19 clinical phenotypes and associated comorbidities and complication profiles.","volume":"16","author":"Lusczek","year":"2021","journal-title":"PLoS One"},{"issue":"8","key":"zoi220109r35","doi-asserted-by":"publisher","first-page":"1599","DOI":"10.1007\/s40520-020-01631-y","article-title":"COVID-19 and the elderly: insights into pathogenesis and clinical decision-making.","volume":"32","author":"Perrotta","year":"2020","journal-title":"Aging Clin Exp Res"},{"issue":"5","key":"zoi220109r36","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1038\/clpt.1992.56","article-title":"Drug concentration response relationships in normal volunteers after oral administration of losartan, an angiotensin II receptor antagonist.","volume":"51","author":"Munafo","year":"1992","journal-title":"Clin Pharmacol Ther"},{"issue":"4","key":"zoi220109r37","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1097\/HJH.0000000000002706","article-title":"Evaluating sources of bias in observational studies of angiotensin-converting enzyme inhibitor\/angiotensin II receptor blocker use during COVID-19: beyond confounding.","volume":"39","author":"Cohen","year":"2021","journal-title":"J Hypertens"},{"issue":"3","key":"zoi220109r39","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1001\/jama.2020.25864","article-title":"Effect of discontinuing vs continuing angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on days alive and out of the hospital in patients admitted with COVID-19: a randomized clinical trial.","volume":"325","author":"Lopes","year":"2021","journal-title":"JAMA"},{"issue":"3","key":"zoi220109r40","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-2600(20)30558-0","article-title":"Continuation versus discontinuation of renin-angiotensin system inhibitors in patients admitted to hospital with COVID-19: a prospective, randomised, open-label trial.","volume":"9","author":"Cohen","year":"2021","journal-title":"Lancet Respir Med"},{"key":"zoi220109r1","unstructured":"Worldometer. COVID-19 coronavirus pandemic. Accessed January 5, 2021. https:\/\/www.worldometers.info\/coronavirus\/"},{"key":"zoi220109r18","unstructured":"Centers for Disease Control and Prevention. Symptoms of COVID-19. Updated January 4, 2021. Accessed January 5, 2021. https:\/\/www.cdc.gov\/coronavirus\/2019-ncov\/symptoms-testing\/symptoms.html"},{"key":"zoi220109r29","doi-asserted-by":"crossref","unstructured":"Puskarich? M, Cummins? NW, Ingraham? N, . Effect of losartan on symptomatic outpatients with COVID-19: a randomized clinical trial.? SSRN. Preprint posted online February 17, 2021. doi:10.2139\/ssrn.3787463","DOI":"10.2139\/ssrn.3787463"},{"key":"zoi220109r38","doi-asserted-by":"crossref","unstructured":"Duarte? M, Pelorosso? FG, Nicolosi? L, ? Telmisartan for treatment of Covid-19 patients: an open randomized clinical trial\u2014preliminary report.? medRxiv. Preprint posted online August 13, 2020. doi:10.1101\/2020.08.04.20167205","DOI":"10.1101\/2020.08.04.20167205"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2790162\/puskarich_2022_oi_220109_1652198565.7699.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,17]],"date-time":"2022-05-17T12:45:19Z","timestamp":1652791519000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2790162"}},"subtitle":["A Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2022,3,16]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2022.2735","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2021.08.25.21262623","asserted-by":"object"}]},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,3,16]]}}}